Hospitalisations are increasing in the US. It's tragic, but FPH is there to help them. I expect them to give a strong forecast for FY22.
Even though a large portion of the US population will be vaccinated, going forward the number of cases will continue to increase as we live with the virus. Even though hospitalisation rates are lower in people who have been vaccinated, the overall number will remain high due to overall increases remaining high in the foreseeable.
The share price has been flat over the past year, due to anticipated decline in sales with the vaccine roll-out; however I suspect they're doing better than expected.
Hospitalisations are increasing in the US. It's tragic, but FPH...
Add FPH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$26.06 |
Change
-0.240(0.91%) |
Mkt cap ! $15.21B | |||
| Open | High | Low | Value | Volume |
| $26.28 | $26.36 | $25.95 | $5.757M | 220.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 171 | $25.95 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $26.06 | 3808 | 2 |
View Market Depth
| Last trade - 16.10pm 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$26.05 |
Change
-0.240 ( 0.74 %) |
||||
| Open | High | Low | Volume | ||
| $26.24 | $26.35 | $25.96 | 277590 | ||
| Last updated 15.59pm 15/05/2024 ? | |||||
| FPH (ASX) Chart |